Displaying 21 - 30 of 11412
Author year
Emerging roles of NudC family: from molecular regulation to clinical implications. Fu Q, Wang W, Zhou T, Yang Y. 2016
Emerging aspergillosis by azole-resistant Aspergillus fumigatus at an intensive care unit in the Netherlands, 2010 to 2013. van Paassen J, Russcher A, In 't Veld-van Wingerden AW, Verweij PE, Kuijper EJ. 2016
A novel comprehensive set of fungal Real time PCR assays (fuPCR) for the detection of fungi in immunocompromised haematological patients-A pilot study. Rahn S, Schuck A, Kondakci M, Haas R, Neuhausen N, Pfeffer K, Henrich B. 2016
Mucormycosis pulmonary abscess, containment in a patient with uncontrolled diabetes mellitus. Jaffer F, Beatty N, Ahmad K. 2017
Antifungal peptides: a potential new class of antifungals for treating vulvovaginal candidiasis caused by fluconazole-resistant Candida albicans. Ng SM, Yap YY, Cheong JW, Ng FM, Lau QY, Barkham T, Teo JW, Hill J, Chia CS. 2017
Mycotic rhinitis in a Mutton Merino ewe. Leask R, Steyl J. 2017
Culture-Positive Pulmonary Aspergillosis Infection: Clinical and Laboratory Features of Solid-Organ Transplant Recipients. Er Dedekarginoglu B, Savas Bozbas S, Ulubay G, Oner Eyuboglu F, Haberal M. 2017
Increased inhibition of cytochrome P450 3A4 with the tablet formulation of posaconazole. Petitcollin A, Crochette R, Tron C, Verdier MC, Boglione-Kerrien C, Vigneau C, Bellissant E, Lemaitre F. 2017
Influence of CYP2C19*2/*17 genotype on adverse drug reactions of voriconazole in patients after allo-HSCT: a four-case report. Beata S, Donata UK, Jarosław D, Tomasz W, Anna WH. 2017
Resistance of Aspergillus fumigatus to Micafungin is Increased by Exogenous β-glucan. Toyoshima T, Ishibashi KI, Yamanaka D, Adachi Y, Ohno N. 2017


Subscribe to Search